Cortical Excitability During de Novo Motor Learning
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorUniversite du Littoral Cote d'Opale
About this trial
De novo motor learning is a specific learning paradigm that allows investigation of how a new motor skill is learned from scratch. Motor task learning can induce increased corticospinal excitability and reorganization of connectivity observed within the motor cortex (M1). Several studies have investigated the plasticity mechanisms underlying motor learning using simple paradigms. The results obtained have been variable, with a major trend toward increased corticospinal excitability, while other results show no increase. We expect to observe a significant increase in excitability and enhanced intracortical reorganization mechanisms within M1 in our subjects during our de novo motor learning sessions.
The primary objective of this study is to measure changes in corticospinal excitability of the motor system across 3 de novo motor learning sessions separated by different time intervals.
The secondary objectives will be: 1) to measure learning across the three practice sessions, 2) to measure changes in inhibition and facilitation across the 3 learning sessions, and 3) to measure correlations between subjects' motor performance and corticospinal and intracortical changes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
right-handed
healthy
having signed an informed consent form
Disqualifiers
counter-indication to transcranial magnetic stimulation
pregnancy
Trial design
Design model
Single group
Treatments tested in this trial
De novo motor learning
BehavioralSubjects will follow 3 sessions of de-novo motor learning (days 1, 2, 8)
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: Motor learningExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in Motor Evoked Potential (MEP) Amplitude Input-Output Curve Assessed by Single-Pulse TMS
Motor Evoked Potential amplitude (mV) recorded from the target muscle (Abductor Pollicis Brevis) in response to increasing TMS intensities. The parameters of the sigmoid input-output curve will be calculated using a Boltzmann function fit.
Time frame
Baseline (Day 1, pre-session), immediately post-session on Day 1, pre-session on Day 2, immediately post-session on Day 2, pre-session on Day 9, and immediately post-session on Day 92
Change in Short-Interval Intracortical Inhibition (SICI) Assessed by Paired-Pulse TMS
Conditioned MEP amplitude expressed as a ratio of unconditioned MEP amplitude (%), using a conditioning stimulus at 80% RMT and inter-stimulus interval of 3 ms.
Time frame
Baseline (Day 1, pre-session), immediately post-session on Day 1, pre-session on Day 2, immediately post-session on Day 2, pre-session on Day 9, and immediately post-session on Day 93
Change in Long-Interval Intracortical Inhibition (LICI) Assessed by Paired-Pulse TMS
Conditioned MEP amplitude as a ratio of unconditioned MEP amplitude (%), using a conditioning stimulus at suprathreshold intensity and inter-stimulus interval of 100ms.
Time frame
Baseline (Day 1, pre-session), immediately post-session on Day 1, pre-session on Day 2, immediately post-session on Day 2, pre-session on Day 9, and immediately post-session on Day 94
Change in Intracortical Facilitation (ICF) Assessed by Paired-Pulse TMS
Conditioned MEP amplitude as a ratio of unconditioned MEP amplitude (%), using a conditioning stimulus at 80% RMT and an inter-stimulus interval of 10ms.
Time frame
Baseline (Day 1, pre-session), immediately post-session on Day 1, pre-session on Day 2, immediately post-session on Day 2, pre-session on Day 9, and immediately post-session on Day 9Secondary outcomes
1
Change in Motor Learning Performance Assessed by Movement Path Length During a 3D Finger-Cursor Task
Path length (mm) of the cursor trajectory during each trial of the motor learning task. Shorter path length indicates more efficient, learned movement.
Time frame
During each motor learning session on Day 1, Day 2, and Day 9Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov